27 employees
Yapan Bio provides process development, scale-up, and cGMP compliant manufacturing of vaccines and biologics/bio-therapeutic.
2019
$13M
from 1 investors over 1 rounds
Yapan Bio raised $13M on December 2, 2021
Investors: Piramal Pharma Solutions